article thumbnail

The drug industry continues to dare regulation

World of DTC Marketing

The study adds further evidence to the idea that drug copay cards are a great short-term deal for patients — and especially the pharma companies that promote them — but a wrong long-term value for healthcare costs. The post The drug industry continues to dare regulation appeared first on World of DTC Marketing.com.

article thumbnail

Four things you need to know about FDA regulations and digital health

pharmaphorum

If you work in pharma, the chances are you’re no stranger to the United States Food and Drug Administration, or FDA, which regulates pharmaceuticals. While the FDA is responsible for regulating both drugs and devices, they’re handled through completely different processes in different parts of the agency.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Delhi HC grants 10 days’ time to Govt to file counter affidavit on petitions against ban of 14 FDCs

AuroBlog - Aurous Healthcare Clinical Trials blog

The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharma companies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]

article thumbnail

UK Regulator Fines Pharma Companies for 10,000% Drug Price Increase

BioSpace

?The CMA said some pharmaceutical firms charge the NHS with excessively high prices for hydrocortisone tablets and paid off potential competitors to stay out of the market.

article thumbnail

Novartis, Genentech and others named in Italian anti-competition probe

Pharmaceutical Technology

Italy’s anti-trust regulator AGCM has launched an anti-competition probe into several pharma companies over alleged anti-competitive conduct.

article thumbnail

Magazine: CRISPR gene therapies cut through in 2023

Pharmaceutical Technology

Artificial intelligence (AI) continues to be in the news, and as pharma companies invest more to make sure they’re ahead of the game, international agencies have also started to catch up with regulations for AI-led healthcare research. We also explore how AI is being used to design digital twins for clinical trials.

article thumbnail

How are pharma companies addressing sustainability and climate change?

Outsourcing Pharma

The pharmaceutical industry is making significant strides toward sustainability, with companies across the sector implementing various Environmental, Social, and Governance (ESG) initiatives.